Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$2,786,927
-$3,087,722 QoQ
Shares Held
164,712
-64.1% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 330 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Derivatives in NTLA

reported options exposure · as of Jun 30, 2026
CallValue
$4,238,460
CallShares
250,500
PutValue
$6,321,312
PutShares
373,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. NTLA ranks #181 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in NTLA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,786,927 164,712
2026-06-30 $4,238,460 250,500
2026-06-30 $6,321,312 373,600
2026-03-31 $5,874,649 458,241
2026-03-31 $5,263,892 410,600
2026-03-31 $3,189,616 248,800
2025-12-31 $3,893,569 433,100
2025-12-31 $8,542,746 950,250
2025-12-31 $6,783,854 754,600
2025-09-30 $178,830 10,355
2025-09-30 $3,169,045 183,500
2025-09-30 $6,477,977 375,100
2025-06-30 $6,659,621 709,981
2025-06-30 $2,261,518 241,100
2025-06-30 $1,752,184 186,800
2025-03-31 $19,606,308 2,757,568
2025-03-31 $725,931 102,100
2025-03-31 $1,667,295 234,500
2024-12-31 $1,370,050 117,500
2024-12-31 $29,080,855 2,494,070
2024-12-31 $3,449,028 295,800
2024-09-30 $1,216,560 59,200
2024-09-30 $2,525,595 122,900
2024-09-30 $20,332,971 989,439
2024-06-30 $2,880,306 128,700
2024-06-30 $17,068,777 762,680
2024-06-30 $2,837,784 126,800
2024-03-31 $1,953,210 71,000
2024-03-31 $2,825,277 102,700
2024-03-31 $24,505,467 890,784
2023-12-31 $5,265,623 172,700
2023-12-31 $38,395,812 1,259,292
2023-12-31 $2,271,505 74,500
2023-09-30 $3,260,022 103,100
2023-09-30 $3,370,692 106,600
2023-09-30 $62,297,186 1,970,183
2023-06-30 $5,925,334 145,300
2023-06-30 $1,517,016 37,200
2023-06-30 $65,436,729 1,604,628
2023-03-31 $43,550,516 1,168,514
2023-03-31 $1,986,491 53,300
2023-03-31 $1,390,171 37,300
2022-12-31 $2,002,686 57,400
2022-12-31 $2,686,530 77,000
2022-12-31 $41,822,118 1,198,685
2022-09-30 $5,170,704 92,400
2022-09-30 $5,260,240 94,000
2022-09-30 $31,177,218 557,134
2022-06-30 $3,892,352 75,200
2022-06-30 $20,390,230 393,938